She then sews, staples, or weaves the material together to create a larger surface, onto which she continues to paint and collage other elements, such as banknotes, price tags, banana stickers ...

A local artist found nearly three decades' worth of National Geographic magazines along the road. It took eight years, but she finally developed a creative idea of what to do with them. Can Kamala ...

Whether you want to overlay text on top of a stunning image or create a collage of photos, this feature provides the flexibility to bring your creative vision to life. Selecting the Perfect Photos ...

Moderna’s shares climbed in the first half of the year, as it scored victories with a product approval and solid clinical trial results. This week the biotech surprised investors with some ...

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Expanding its portfolio into oncology and rare diseases, positions Moderna to deliver ten product approvals within the next three years. The analyst notes the COVID-19 vaccine maker pushed its ...

Over the past year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider transactions, it is usually ...

Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day, spotlighting its mRNA-based pipeline and revised financial plans. CEO Stéphane Bancel emphasized the company’s ...

Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even. The company also ...

TORONTO - Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating variants of the virus. The mRNA vaccine, called Spikevax, has been ...

Moderna, the Massachusetts-based biotech company that rocketed into the global spotlight during the development of its COVID-19 vaccine, announced plans on Thursday to cut costs and refocus on ...